{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:19:28Z","timestamp":1791231568036,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.det.2011.06.007","type":"journal-article","created":{"date-parts":[[2011,8,7]],"date-time":"2011-08-07T14:54:56Z","timestamp":1312728896000},"page":"663-671","source":"Crossref","is-referenced-by-count":17,"title":["Diagnosis and Treatment of Patients with Autoimmune Bullous Disorders in Germany"],"prefix":"10.1016","volume":"29","author":[{"given":"Enno","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2011.06.007_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1046\/j.1468-3083.2002.00384.x","article-title":"Increased incidence of pemphigus vulgaris in southern Europeans living in Germany compared with native Germans","volume":"16","author":"Hahn-Ristic","year":"2002","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2011.06.007_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.06.007_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib5","first-page":"399","article-title":"Diagnostic and therapy of autoimmune blistering diseases","volume":"108","author":"Schmidt","year":"2011","journal-title":"Dtsch Arztbl Int"},{"key":"10.1016\/j.det.2011.06.007_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.det.2011.06.007_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1046\/j.1439-0353.2004.04702.x-i1","volume":"2","author":"Goebeler","year":"2004","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.06.007_bib8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2004.02.013","article-title":"Management of autoimmune bullous diseases: pharmacology and therapeutics","volume":"51","author":"Mutasim","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib9","article-title":"Interventions for bullous pemphigoid","volume":"3","author":"Khumalo","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2011.06.007_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006263.pub2","article-title":"Interventions for pemphigus vulgaris and pemphigus foliaceus","volume":"1","author":"Martin","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.det.2011.06.007_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/157016309789869065","article-title":"Current treatment of autoimmune blistering diseases","volume":"6","author":"Kasperkiewicz","year":"2009","journal-title":"Curr Drug Discov Technol"},{"key":"10.1016\/j.det.2011.06.007_bib12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br\u00a0J Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1610-0387.2008.06872.x","article-title":"Results of a survey of German dermatologists on the therapeutic approaches to pemphigus and bullous pemphigoid","volume":"7","author":"Hofmann","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.06.007_bib16","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/jid.2008.412","article-title":"A\u00a0comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study","volume":"129","author":"Joly","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A\u00a0comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2011.06.007_bib18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib19","first-page":"205","article-title":"Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases","volume":"76","author":"Schmidt","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.det.2011.06.007_bib20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A\u00a0randomized double-blind trial of intravenous immunoglobulin for\u00a0pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell-directed therapy for inflammatory skin diseases","volume":"129","author":"Nagel","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A\u00a0single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2011.06.007_bib23","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.det.2011.06.007_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1749-6632.2009.04744.x","article-title":"Rituximab in severe pemphigus","volume":"1173","author":"Schmidt","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.det.2011.06.007_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/17469872.3.3.259","article-title":"CD20-directed therapy in autoimmune diseases involving the skin: role of rituximab","volume":"3","author":"Schmidt","year":"2008","journal-title":"Expert Rev Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib26","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1046\/j.1365-2133.2003.05302.x","article-title":"Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus","volume":"148","author":"Schmidt","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000090659","article-title":"Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption","volume":"212","author":"Eming","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2011.06.007_bib28","first-page":"S97","article-title":"Successful treatment of severe pemphigus with the combination of immunoadsorption and rituximab","volume":"129","author":"Shimanovich","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2133.2007.08358.x","article-title":"Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins","volume":"158","author":"Shimanovich","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1365-2230.2006.02220.x","article-title":"Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption","volume":"31","author":"Shimanovich","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2011.06.007_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","article-title":"Immunoadsorption in dermatology","volume":"302","author":"Schmidt","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.det.2011.06.007_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1610-0387.2007.06342.x","article-title":"Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases","volume":"5","author":"Zillikens","year":"2007","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.06.007_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1610-0387.2007.06602.x","article-title":"Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases","volume":"6","author":"Hertl","year":"2008","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.06.007_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1610-0387.2009.07118.x","article-title":"Use of high-dose immunoglobulins in dermatology","volume":"7","author":"Enk","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2011.06.007_bib35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1610-0387.2010.07380.x","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"J\u00a0Dtsch Dermatol Ges"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351100115X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351100115X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T21:53:51Z","timestamp":1543614831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351100115X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S073386351100115X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2011.06.007","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}